Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 19 Jan 2010
At a glance
- Drugs Cisplatin (Primary) ; UCN 01 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 19 Jan 2010 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 19 Jan 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 25 Oct 2007 Status changed from in progress to completed.